The global Antihistamine Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Antihistamine Drugs market's development status and future trend in the global and Japan. It splits Antihistamine Drugs market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
Akorn Pharmaceuticals (US)
Almirall S.A. (Spain)
Auctus Pharma Limited (India)
Bayer SA-NV (Belgium)
Kyowa Hakko Kirin Co.,Ltd. (Japan)
MEDA Pharma GmbH & Co. KG (Germany)
Merck Sharp & Dohme Limited (UK)
Nippon Boehringer Ingelheim Co.,Ltd. (Japan)
Pfizer Pharmaceutical Company (US)
Sanofi Winthrop Industries (France)
Santen Pharmaceutical Co.,Ltd. (Japan)
Schering-Plough Europe (US)
Sun Pharmaceutical Industries Ltd. (India)
Teva Pharmaceutical Industries (Israel)
Therabel Europe Limited (Ireland)
UCB Pharma GmbH (Germany)
Vintage Pharmaceuticals (US)

Geographically, this report splits the Global market into the following regions:
Asia Pacific
Japan
Tokyo
Yokohama
Osaka
Nagoya
Others
China
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others

On the basis of product, the Antihistamine Drugs market is primarily split into
By Antihistanmines
Azelastine
Brompheniramine
Carbinoxamine
Cetirizine
Other
By Access
Prescription
OTC

Key Applications
Department of respiration
Otolaryngology
Department of dermatology
Pharmacy